Home Based Treatment for Drug Use in Early Adolescents
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00280228 |
Recruitment Status :
Completed
First Posted : January 20, 2006
Last Update Posted : May 26, 2011
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Attention Deficit Hyperactivity Disorder Oppositional Defiant Disorder Conduct Disorder Substance Abuse | Behavioral: Adolescent Skills Parent Management Parent-Adol Negotiation Behavioral: Treatment as Usual | Phase 2 |
In this study phase, 36 patients with a disruptive behavior disorder (DBD - i.e., attention deficit-hyperactivity disorder, oppositional defiant disorder, conduct disorder) and use or abuse of one or more substances will be randomly assigned to treatment using either a standard treatment for DBDs in this age group or the newly developed HBT treatment. Treatment outcomes for the 24 patients assigned to receive HBT will then be compared to outcomes for the 12 patients assigned to receive standard DBD treatment.
Specific aims of Phase II include:
- finalizing the HBT treatment manual and measures of treatment fidelity, therapist competence, and treatment satisfaction;
- generating estimates of treatment effect sizes for substance use, disruptive behavior, and functional status outcomes, as pilot data for a larger efficacy study, and
- comparing treatment satisfaction for the two treatment groups.
We hypothesize that HBT will lead to significantly lower rates of disruptive behaviors, substance use, and SUDs than with standard treatment, as well as greater concomitant improvements in impairment.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 36 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Home-based Behavioral Therapy (HBT): Psychosocial Intervention Project for Early Adolescents With Pre- or Early Substance Use Disorder: Phase II |
Study Start Date : | January 2006 |
Actual Primary Completion Date : | May 2009 |
Actual Study Completion Date : | May 2009 |

Arm | Intervention/treatment |
---|---|
Experimental: 1
Home Based Treatment
|
Behavioral: Adolescent Skills Parent Management Parent-Adol Negotiation
Acute treatment for 12 weeks followed by three monthly booster sessions. |
Active Comparator: 2
Treatment as Usual
|
Behavioral: Treatment as Usual
Standard outpatient treatment for behavioral problems and substance use |
- Rates of substance use and disruptive behaviors [ Time Frame: immediately following acute 12 week treatment, at the end of 3 month followup, and at one year follow up ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 11 Years to 14 Years (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Study participants (subjects and parents) must provide written consent and verbal assent
- Adolescents aged 11 through 14 of any race or ethnic background,
- A DSM-IV disruptive behavior disorder diagnosis (either CD, ODD, ADHD or disruptive behavior disorder not otherwise specified [DBD NOS]),
- Adolescents who are either using one or more substances regularly (2 or more times a month for 3 consecutive months), and
- Acceptable insurance coverage (i.e., participant has insurance that is accepted by the University of Pittsburgh Medical Center [UPMC] in the event that they are randomly assigned to the treatment-as-usual [TAU] group).
Exclusion Criteria:
- Full scale IQ below 80;
- History of pervasive developmental disorder, schizophrenia or other psychotic disorders, organic mental disorders or eating disorders,
- Diagnosis of bipolar disorder,
- Recent treatment for substance problems, and/or
- Daily use of "hard" street drugs (i.e., cocaine, methamphetamine, heroin, inhalants).

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00280228
United States, Pennsylvania | |
Youth and Family Research Program | |
Pittsburgh, Pennsylvania, United States, 15213 |
Principal Investigator: | Oscar G Bukstein, M.D., M.P.H. | University of Pittsburgh |
Responsible Party: | Oscar G. Bukstein, M.D., M.P.H., University of Pittsburgh |
ClinicalTrials.gov Identifier: | NCT00280228 |
Other Study ID Numbers: |
DA016631 5R21DA016631 ( U.S. NIH Grant/Contract ) |
First Posted: | January 20, 2006 Key Record Dates |
Last Update Posted: | May 26, 2011 |
Last Verified: | May 2011 |
ADHD Oppositional Defiant Disorder Conduct Disorder Substance Use Drug and Alcohol Use |
Disease Substance-Related Disorders Attention Deficit Disorder with Hyperactivity Conduct Disorder Attention Deficit and Disruptive Behavior Disorders |
Pathologic Processes Neurodevelopmental Disorders Mental Disorders Chemically-Induced Disorders |